Eli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.

Eli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.

No replies yet.